Corporate Banner
Satellite Banner
Biomolecular Screening
Scientific Community
Become a Member | Sign in
Home>Products>This Product

POLARstar Optima Multimode Plate Reader with FP

Product Description

The POLARstar OPTIMA is a full multimode microplate reader which incorporates Simultaneous Dual Emission detection for fluorescent polarization. The POLARstar OPTIMA offers five different measurement principles:

• Fluorescence Polarization
• Fluorescence Intensity - including FRET
• Time-Resolved Fluorescence - including DELFIA®
• High-Performance Luminescence (flash and glow)- including BRET
• Absorbance - UV/Vis with path length correction

The POLARstar OPTIMA is designed for the widest possible range of non-radioactive labeled applications:

• Ca2+ Measurements (e.g. Ca2+Flux with Fura-2 or Indo-1)
• Molecular Interactions
• Enzyme Activity
• Cell Toxicity, Proliferation and Viability
• ATP Quantification
• Immunoassays
• Kinase, cAMP, and other second messenger signaling
• DNA/RNA quantification
• GFP and other fluorescent protein cell-based assays
• And many more…

The POLARstar OPTIMA is a multimode microplate reader that covers the wavelength range from 240 – 740 nm (900 nm optional). The POLARstar OPTIMA reads all plate formats from 6- up to 384-well. Top and bottom reading are standard, and the dual-channel detection system can be used for fluorescence polarization as well as dual emission wavelength measurements like FRET or BRET. Incubation up to 45°C or 60°C, gas vent connection, up to two built-in reagent injectors, fast filter wheels, and the ability to define up to 8 sets of filters are just some of the outstanding features found in the POLARstar OPTIMA.

Complete Software Package
The POLARstar OPTIMA comes with BMG LABTECH's established OPTIMA Reader Control Software and comprehensive MARS Data Analysis Software. The familiar and highly visual OPTIMA reader control software provides limitless possibilities for test set up and is fully compliant with FDA regulation 21 CFR Part 11. The well-organized Data Analysis Software – MARS – offers a Template Manager for building complex data processing protocols and a Wizard-guided interface to create easy step-by-step calculations, and much more.
Product POLARstar Optima Multimode Plate Reader with FP
Company BMG Labtech GmbH
Price Request a quote
More Information View company product page
Catalog Number Unspecified
Quantity Unspecified
Company Logo

BMG Labtech GmbH
Allmendgruen 8, 77799 Ortenberg Germany

Tel: +49 781 96968-0
Fax: +49 781 96968-67

Scientific News
Mass Spec Technology Drives Innovation Across the Biopharma Workflow
With greater resolving power, analytical speed, and accuracy, new mass spectrometry technology and techniques are infiltrating the biopharmaceuticals workflow.
Targeting Cannabinoid CB2 Receptors in the CNS
With endogenous cannabinoids considered as a potential target to combat CNS diseases, this article examines the role of CB2R could play in fighting some disorders.
Bacterial Genes Boost Current in Human Cells
Borrowing and tweaking bacterial genes to enhance electrical activity might treat heart, nervous system injury.
Less Frequent Cervical Cancer Screening
HPV-vaccinated women may only need one screening every 5 to 10 years with screening starting later in life.
Cocoa Compound Linked to Some Cardiovascular Biomarker Improvements
The study highlights the urgent need for large, long-term RCTs that improve understanding of how the short-term benefits of cocoa flavanol intake on cardiometabolic biomarkers may be translated into clinical outcomes.
Untangling a Cause of Memory Loss in Neurodegenerative Diseases
The mouse study identifies a possible therapeutic target for a family of disorders.
New Pathway for COPD Biomarker Development
A study from Philip Morris International has highlighted multi-lipid profiling as a potential new pathway for COPD biomarker development.
Stiffening a Blow to Cancer Cells
Researchers develop a way to predict how a tumor tissue's physical properties affect its response to chemotherapy drugs.
Anti-Cancer Drug Uses Tumour mRNA to Identify Responders
Phase I study of novel anti-cancer drug uses tumour mRNA expression to identify patients who will respond to the drug.
New Strategy for Choosing Cancer Drugs
Device can predict tumor responses by measuring cell growth after drug exposure.

Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,100+ scientific videos